GE Healthcare Omnipaque 300 contrast injection recalled for particulate matter
GE Healthcare is recalling Omnipaque (iohexol) Injection, 300 mg/mL, over the presence of particulate matter. The action covers 866,570 vials distributed nationwide.
- Product
- OMNIPAQUE — OMNIPAQUE (IOHEXOL)
- Category
- Drug
- Distribution
- Distributed nationwide